Dr. & Mrs. Louis Izenstein Lecture for Education & Research in Diabetes and Endocrinology

Objectives

After participating in this educational activity, attendees should be able to:
1| Identify those who are most likely to benefit from screening for pre-symptomatic type 1 diabetes.
2| Describe the stages of type 1 diabetes.
3| Interpret to some degree type 1 diabetes related autoantibody results and convey the associated risk of symptomatic disease development.
 
 
Presenter(s): 
Jason Gaglia, MD, MMSc
Assistant Investigator and Staff Physician
Section Head, Clinical, Behavioral and Outcomes Research
Director, Hood Center for the Prevention of Childhood Diabetes
Co-Director, Clinical Translational Research Core
Assistant Professor of Medicine, Harvard Medical School
Beth Israel Lahey Health-Joslin Diabetes Center

 

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Jason Gaglia, MD, MMSc Speaker Dr. Gaglia has listed financial relationships with the following companies: Vertex Pharmaceuticals (consultant and stock owner), AstraZeneca (consultant), Sanofi (grant to institution), Biomea Fusion (grant to institution), COUR Pharmaceuticals (consultant), GentiBio (grant to institution), and Diamyd Medical (grant to institution). no
Session date: 
10/01/2025 - 8:00am to 9:00am EDT
Location: 
Baystate Medical Center
759 Chestnut Street
Chestnut Conference Room 1A & B & Webinar
Springfield, MA 01199
United States
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.